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The mitochondrial membrane potential is
central to the organelle’s many functions.
Combining mitochondria targeted
probes, click chemistry, and mass
spectrometry, Logan et al. develop a
highly sensitive approach to assess small
changes in membrane potential in cells
and in vivo, and show its utility in proof-
of-principle experiments.
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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARY
The mitochondrial membrane potential (Dcm) is a
major determinant and indicator of cell fate, but it
is not possible to assess small changes in Dcm
within cells or in vivo. To overcome this, we devel-
oped an approach that utilizes two mitochondria-
targeted probes each containing a triphenylphos-
phonium (TPP) lipophilic cation that drives their
accumulation in response to Dcm and the plasma
membrane potential (Dcp). One probe contains
an azido moiety and the other a cyclooctyne,
which react together in a concentration-dependent
manner by ‘‘click’’ chemistry to form MitoClick. As
the mitochondrial accumulation of both probes de-
pends exponentially on Dcm and Dcp, the rate of
MitoClick formation is exquisitely sensitive to small
changes in these potentials. MitoClick accumulation
can then be quantified by liquid chromatography-
tandem mass spectrometry (LC-MS/MS). This
approach enables assessment of subtle changes
in membrane potentials within cells and in the
mouse heart in vivo.
INTRODUCTION
The mitochondrial membrane potential (Dcm) is central to the
organelle’s many functions (Nicholls and Ferguson, 2013). As
electrons pass down the respiratory chain to oxygen, the differ-
ence in reduction potential drives proton pumping across the
inner membrane, generating a proton electrochemical potential
gradient comprising a pH gradient (0.8 pH units/50 mV, basicCell Minside) and a Dcm (120–180 mV, negative inside); thus Dcm is
by far the dominant component. The central function of Dcm is
to drive ATP synthesis by oxidative phosphorylation, and its
magnitude is set by the balance between its generation and
its consumption by ATP synthesis and other dissipative pro-
cesses (Figure 1A), making Dcm a sensitive indicator of cellular
energetics. Dcm can decrease due to elevated ATP production
or thermogenesis, or from mitochondrial dysfunction, while
Dcm can increase due to diminished ATP synthesis or an upre-
gulation of proton pumping. Such increases occur in apoptosis
and cancer (Smith et al., 2012; Wallace et al., 2010). An in-
crease in Dcm is also a key driver of mitochondrial ROS pro-
duction in pathology and redox signaling (Murphy, 2009).
Consequently, many biomedically central phenomena are
associated with subtle changes in Dcm, and the ability to quan-
tify these alterations in vivo and in cells should enable mecha-
nistic insights and facilitate novel approaches to diagnosis and
therapies (Figure 1A).
Changes in Dcm within cells can be assessed using fluores-
cent or radiolabeled lipophilic cations; however, these ap-
proaches are insensitive to small changes (Davidson et al.,
2007; Perry et al., 2011) and can only be used in restricted situ-
ations in vivo (Davidson et al., 2007; Sack, 2006). Hence we have
developed a sensitive method to assess small changes in Dcm
and Dcp, in cells and in vivo. For this we direct probes to mito-
chondria using a triphenylphosphonium (TPP) lipophilic cation
(Ross et al., 2005; Smith et al., 2011, 2012). The large hydropho-
bic surface area of the TPP cation enables its rapid, several-hun-
dred-fold accumulation into cells in response to the Dcp and
from there into mitochondria in response to Dcm (Ross et al.,
2005). To assess relative changes inDcm andDcp, we administer
two TPP compounds simultaneously, both of which accumulate
within mitochondria and react together to form a stable product
(Figure 1B). The reaction rate is proportional to the local concen-
trations of both reactants, each of which accumulates inetabolism 23, 379–385, February 9, 2016 ª2016 The Authors 379
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Figure 1. Rationale for Mitochondria-Tar-
geted Click Chemistry to Assess Dcm
(A) Dcm in vivo. This shows a mitochondrion with
the respiratory chain generating Dcm by pumping
protons across the inner membrane. The Dcm is
used to synthesize ATP. Situations in which the
steady-state level of Dcm within cells and in vivo
change are indicated.
(B) The structures of MitoAzido and MitoOct are
shown along with their uptake into the cell in
response to the plasmamembrane potential (Dcp)
and then intomitochondria in response to theDcm
across the inner membrane in vivo, followed by
their click reaction together to form MitoClick as a
regioisomeric mixture.
(C) The rate of MitoClick formation in the mito-
chondrial matrix divided by the rate in the cytosol
as a function of Dcm, with the cytosolic concen-
trations of MitoAzido and MitoOct held constant.
Equation 2, which describes this curve, is shown.
See also Figure S1.mitochondria 102- to 103-fold driven by Dcp and Dcm, hence
product formation there will be 104- to 106-fold faster than
that in the cytosol and will be extremely sensitive to small
changes in Dcm and Dcp (Figure 1B).
For this to work, the two probes must react specifically with
each other and not with other biomolecules. To achieve this,
we used ‘‘click’’ chemistry, which utilizes azido and alkyne
groups, which couple ex vivo under Cu(I) catalysis (Kolb et al.,
2001). To enable the reaction to occur in vivo without catalysis,
Bertozzi developed strained cyclooctynes (Agard et al., 2004;
Jewett and Bertozzi, 2010). Therefore we prepared TPP com-
pounds containing cyclooctyne (MitoOct) and azido (MitoAzido)
moieties, which react together to form MitoClick (Figure 1B).
The rate of the reaction of MitoOct with MitoAzido to form
MitoClick is
RateMitoClick =K½MitoAzido½MitoOct (1)
where k is the second order rate constant. As shown in Supple-
mental Information, available online, the ratio of the rates of







Thus, there is an exponential dependence of the rate enhance-
ment on Dcm over the biologically relevant range from 120 to
180 mV (Figure 1C) (Brand and Murphy, 1987; Porteous et al.,
1998), assuming no confounding changes in Dcp. Differentiation












31: (3)380 Cell Metabolism 23, 379–385, February 9, 2016 ª2016 The AuthorsTherefore every 1 mV Dcm increase
accelerates mitochondrial MitoClick for-
mation relative to that in the cytosol
800-fold at 120 mV and 80,000-fold
at 180 mV. This leads to an 8% com-pounded increase in MitoClick formation per mV, making very
small relative changes in Dcm easy to assess (Figure 1C). It is
essential to note that, as with all methods dependent on lipo-
philic cation accumulation, the accumulation of MitoClick will
also be sensitive to small changes inDcp. Alteration of mitochon-
drial, cell, and extracellular volumes, and excretion and binding,
will also affect the rate of MitoClick formation. Consequently,
while in all cases small changes in Dcm will dramatically alter
MitoClick formation rate, it is vital to consider the many con-
founding factors that could impact on measurements.
To quantify the amount of MitoClick formed within tissues, we
use liquid chromatography-tandemmass spectrometry (LC-MS/
MS) relative to deuterated internal standards, which enables
sensitive detection of TPP probes (Cocheme´ et al., 2011). Here
we describe the development and application of mitochondria-
targeted click reagents to assess small changes of Dcm in cells
and in vivo.
RESULTS AND DISCUSSION
Uptake of MitoOct and MitoAzido Forms MitoClick
within Energized Mitochondria
The syntheses of MitoOct and MitoAzido are shown in Figures
S1A and S1B. Reaction of MitoOct with MitoAzido gave only
MitoClick (Figure S1C) as a 1:1 mixture of regioisomers, deter-
mined by 1H-NMR and high-resolution mass spectrometry (Sup-
plemental Information). RP-HPLC also showed that MitoOct and
MitoAzido reacted together to form MitoClick under biological
conditions (Figure 2A). We used an ion-selective electrode to
show that MitoOct and MitoAzido were taken up by energized




Figure 2. ReactionofMitoOct andMitoAzido
to FormMitoClick in Mitochondria
(A) MitoOct and MitoAzido (10 nmol of each) were
incubated in 250 mL KCl medium at room tem-
perature for the indicated times and then analyzed
by RP-HPLC. The double peak for MitoClick by
RP-HPLC is due to the formation of the two
MitoClick regioisomers.
(B) Isolated mitochondria were incubated in the
chamber of an ion-selective electrode, and the
response was calibrated by 5 3 1 mM successive
additions of MitoAzido, MitoOct, or MitoClick.
Where indicated mitochondria, succinate and
FCCP were added.
(C) Mitochondria were incubated with MitoAzido
(5 mM) and MitoOct (5 mM) for the indicated times,
pelleted, and extracted with ACN and the extract
analyzed by RP-HPLC.
(D) Typical LC-MS/MSchromatogramsshowing the
m/z transitions measured simultaneously for 50 nM
each of MitoAzido, d15-MitoAzido, MitoOcttet, d15-
MitoOcttet, MitoClick, and d30-MitoClick. Traces are
normalized to the maximum total ion count
measured during that experiment. See also Fig-
ure S2 and Tables S1 and S2.(FCCP) (Figure 2B). The uptake for MitoOct or MitoAzido
(1–1.5 nmol/mg protein) (Figure 2B), corresponds to 2–3 mM
in the matrix (assuming 0.5 ml/mg protein [Ross et al., 2008]
and uncorrected for binding), 1,000-fold greater than the
external concentration (3 mM), consistent with Dcm-dependent
uptake. MitoClick mitochondrial uptake was 3–3.5 nmol/mg
protein (Figure 2B), about 6–7 mM in the matrix, 10,000-fold
greater than the external concentration (0.5 mM), more than its
monocationic precursors, as expected for a dication (Ross
et al., 2006).
To see if MitoClick formation was enhanced by mitochondrial
accumulation of its precursors, we incubated MitoOct and
MitoAzido with mitochondria and measured MitoClick formation
(Figure 2C). There was extensiveMitoClick generation after 1min
with mitochondria (Figure 2C), compared to negligible formation
over 1 hr without mitochondria (Figure 2A), and this MitoClick
formation was prevented by FCCP (Figure 2C). Therefore, both
MitoOct and MitoAzido are extensively accumulated by mito-
chondria in response to Dcm, dramatically increasing the rate
of MitoClick formation.Cell Metabolism 23, 379–385LC-MS/MS Analysis of MitoClick
Formation from MitoOct and
MitoAzido
The measurement of MitoClick formation
in vivo necessitates LC-MS/MS detec-
tion, because RP-HPLC is too insensitive.
However, LC-MS/MS requires solvent
extraction followed by evaporation under
vacuum (Cocheme´ et al., 2011), greatly
concentrating unreacted MitoAzido and
MitoOct which would lead to extensive
ex vivo MitoClick formation. To prevent
this we used a blocking reagent,
3-phenyl-1,2,4,5-tetrazine (Tet), whichreacts very rapidly with MitoOct to generate MitoOcttet (Fig-
ure S2A) (Karver et al., 2012). The reaction of Tet with MitoOct
(k 12.1 3 106 M1s1 [Balcar et al., 1983]) is 108-fold faster
than that for MitoAzido (k 0.1–0.2 M1s1). Including Tet in
the extraction solution prevented artifactual MitoClick formation
(Figure S2B; Table S1).
To establish LC-MS/MS assays, we fragmented MitoClick,
MitoOcttet, and MitoAzido and analyzed the product ions to
select mass transitions for quantification (Table S2). These tran-
sitions are selective for the intended species by LC-MS/MS (Fig-
ure 2D). From these, standard curves were established for
MitoAzido, MitoOcttet and MitoClick in tissue homogenates
with detection down to 1–5 pmol per g wet weight tissue (Fig-
ure S2C). This approach was used to assess the rate of reaction
of MitoOct and MitoAzido in solution (Figures S2D and S2E).
Analysis of MitoClick Formation in Mitochondria and
Cells
Formation of MitoClick from MitoAzido and MitoOct in isolated






C Figure 3. Assessment of MitoClick Forma-
tion by LC-MS/MS in Mitochondria and Cells
(A) Detection of MitoAzido, MitoOcttet, and
MitoClick in mitochondria. Rat liver mitochondria
(1 mg protein/mL) were incubated with 5 mM of
MitoAzido and MitoOct in KCl medium at 37C.
Samples were removed at the indicated times, and
mitochondria were pelleted, quenched with Tet,
and then extracted and analyzed by LC-MS/MS.
Data are means ± SEM of three separate mito-
chondrial preparations.
(B) Detection of MitoClick in mitochondria. Rat liver
mitochondria were incubated as in (A) for 5 min ±
FCCP (500 nM) or nigericin.
(C) Effect of malonate on MitoClick formation in
mitochondria. Rat liver mitochondria were incu-
bated as in (A) for 5 min with increasing concen-
trations of malonate. Samples were removed,
quenchedwith Tet, then extracted and analyzed by
LC-MS/MS. Data are means ± SEM of three repli-
cates.
(D) Detection of MitoAzido, MitoOcttet, and
MitoClick in cells. C2C12 cells were incubated with
5 mM each of MitoAzido and MitoOct for up to 3 hr.
The supernatant was removed and the cell layer
was scraped into PBS, and both were quenched
with Tet, extracted, and analyzed by LC-MS/MS.
Data are means ± SEM of three independent ex-
periments.
(E) Oxygen consumption rate (OCR) measured in
C2C12 cells. Where indicated, oligomycin (4 mM),
FCCP (2 mM), and rotenone/antimycin (4 mg/mL)
were added. Each point is the mean ± range of
measurements on two wells.
(F) Detection of changes in Dcm using TMRM
staining in cells. C2C12 cells were treated with
100 nM TMRM and 500 ng/mL Hoescht 33342 for
15 min prior to imaging. Cells were imaged on a
temperature-control stage of a Nikon Eclipse Ti
microscope using 633 oil immersion lens. Where
indicated, additions of oligomycin (4 mM) and
FCCP (2 mM) were made directly to the cultured
cells.
(G) Assessment of changes in Dcm using TMRM staining in cells. Fluorescence intensity of eight cells per experiment evaluated using Nikon elements software.
Data shown are means ± SEM of three independent experiments.
(H) Effect of FCCP and oligomycin onMitoClick formation in cells. C2C12 cells were incubated with 5 mMeach of MitoAzido andMitoOct alone or with oligomycin
(1 mg/mL) or FCCP (2 mM) as indicated for 3 hr. The cell layer was scraped into PBS, quenched with Tet, extracted, and analyzed by LC-MS/MS.
(I) Assessment of changes in Dcm due to mitochondrial inhibitors using TMRM staining in cells. Fluorescence intensity of eight cells per experiment after 15 min
incubation was assessed as in (G). Incubations contained no further additions (control), rotenone (4 mg/mL) (rot), rotenone (4 mg/mL), and antimycin (4 mg/mL)
(rot/ant) or rotenone (4 mg/mL), antimycin (4 mg/mL), and oligomycin (1 mg/mL) (rot/ant/olig). Data shown are means ± SEM of three independent experiments.
(J) Effect of mitochondrial inhibitors onMitoClick formation in cells. C2C12 cells were incubated with 5 mMeach ofMitoAzido andMitoOct alone (cont) or rotenone
(4 mg/mL) (rot), rotenone (4 mg/mL), and antimycin (4 mg/mL) (rot/ant) or rotenone (4 mg/mL), antimycin (4 mg/mL), and oligomycin (1 mg/mL) (rot/ant/olig) as
indicated for 3 hr. The cell layer was scraped into PBS, quenched with Tet, extracted, and analyzed by LC-MS/MS. Data are means ± SEM of three independent
experiments. *p < 0.05, **p < 0.01, ***p < 0.001 assessed by Student’s t test relative to untreated control.levels of MitoOcttet and MitoAzido were stable over 5 min, while
MitoClick increased, consistent with formation in mitochondria
(Figure 3A). Abolition of Dcm with FCCP prevented MitoClick for-
mation, while increasing Dcm with nigericin increased its gener-
ation (Figure 3B). Gradually decreasing Dcm with the respiratory
inhibitor malonate led to a corresponding decrease in MitoClick
(Figure 3C). ThusMitoClick formation inmitochondria is sensitive
to small changes in Dcm.
When we incubated MitoAzido and MitoOct with cells,
MitoClick increased over time in both the supernatant and cells
(Figure 3D). To see how MitoClick formation responded to small382 Cell Metabolism 23, 379–385, February 9, 2016 ª2016 The Authochanges of Dcm, we assessed Dcm alterations that are likely to
occur in cells, illustrated by oxygen consumption rate (OCR)
measurements (Figure 3E). Under basal respiration, mitochon-
dria make ATP and have a submaximal Dcm; oligomycin inhibits
ATP synthesis maximizing Dcm and decreasing OCR; finally,
FCCP abolishes Dcm andmaximizes OCR (Figure 3E). The asso-
ciated subtle changes inDcm are less easily assessed, as is illus-
trated using a current benchmark for Dcm investigation, the
fluorescence of tetramethylrhodamine (TMRM) in nonquenching
mode (Figures 3F and 3G). Increasing Dcm from its normal value
to its maximum with oligomycin gave only a small change inrs
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Figure 4. Assessment of MitoClick Forma-
tion by LC-MS/MS in Mice
(A) Detection of MitoAzido, MitoOcttet, and
MitoClick in mouse heart. Mice were injected i.v.
with 50 nmol each of MitoAzido and MitoOct,
and after the indicated times the heart
was removed and MitoAzido, MitoOcttet, and
MitoClick were analyzed by LC-MS/MS. Data are
means ± SEM of three mice per time point. See
also Figure S3.
(B and C) Effect of DNP on MitoClick formation
within the mouse heart. Mice were injected i.v.
with 10 nmol each of MitoAzido and MitoOct
at various times after DNP administration,
then 1 min later the heart was removed and
MitoAzido, MitoOcttet, and MitoClick analyzed by
LC-MS/MS. In (B) MitoAzido and MitoOct were
injected 15 min after i.p. administration of DNP
(1 mg/kg). Data are means ± SEM of eight mice.
In (C) mice were administered DNP (5 mg/kg) by
oral gavage, and 60 min later MitoAzido and
MitoOcttet were injected. Data are means ± SEM
of five mice.
(D) Complex I activity in the hearts of Ndufs4-null
mice. Heart mitochondria from Ndufs4-null and
wild-type control mice were isolated and the
complex I activity was measured. Data are
means ± SEM of four independent mitochondrial
preparations.
(E) MitoClick formation in the heart ofNdufs4-null mice. Mice were injected with MitoAzido andMitoOct and after 1 minMitoClick was analyzed as in (A). Data are
mean ± SEM of four mice.
(F) Citrate synthase activity in the hearts of Ndufs4-null mice. Heart mitochondria from Ndufs4-null and wild-type control mice were isolated and citrate synthase
activity was measured. Data are means ± SEM of 4 independent mitochondrial preparations.
(G) Dcm of isolated heart mitochondria from Ndufs4-null mice. Heart mitochondria from Ndufs4-null and wild-type control mice were incubated with 10 mM
succinate, and Dcm was measured from the distribution of [
3H]-TPMP. Data are means ± SEM of six independent mitochondrial preparations. See also
Figure S3.fluorescence (Figures 3F and 3G). In contrast, the same increase
in Dcm dramatically enhanced MitoClick formation (Figure 3H).
Similarly, inhibition of respiration by rotenone and/or antimycin
showed a far greater change in MitoClick than TMRM (Figures
3I and 3J). Subsequent addition of oligomycin further lowered
Dcm by inhibiting proton pumping by the ATP synthase (Figures
3I and 3J). Therefore MitoClick formation is exquisitely sensitive
to small changes in Dcm within cells (Figure 1C).
Use of MitoClick Formation to Assess Relative Changes
in Dcm within Mice
Methods to assess subtle changes in Dcm in mice in vivo have
long been sought. TPP can target a wide range of compounds
to mitochondria within mice, following intravenous (i.v.) adminis-
trationwith rapid (minutes) mitochondrial uptakewithin the heart,
liver, and kidney (Porteous et al., 2010; 2013; Smith et al., 2011,
2012). MitoAzido and MitoOct could be given safely i.v. by tail
vein injection to mice; therefore over the next 3 hr we measured
their levels and those of MitoClick in the heart (Figure 4A). There
was an initial increase in MitoOct and MitoAzido content, as ex-
pected due to the rapid uptake of TPP compounds by the heart in
response to Dcp and Dcm (Porteous et al., 2010, 2013). These
compounds were lost with half-lives of 0.8 hr, due to their re-
equilibration across membranes followed by excretion in the
urine and bile (Smith et al., 2011). There was rapid initial
MitoClick formation, due to the high MitoAzido and MitoOctCell Mmitochondrial concentrations immediately following injection
(Figure 4A). MitoClick formation was sustained for a short time
and then stopped, as the precursors became depleted (Fig-
ure 4A). MitoClick was retained longer due to its double positive
charge (Ross et al., 2006) (Figure 4A). The kidney showed less
MitoAzido and MitoOct uptake than the heart, and the apparent
rate of excretion was slower, consistent with redistribution from
other organs (Figure S3B). There was uptake of MitoAzido and
MitoOct into the liver (Figure S3B); however, MitoOct and
MitoClick were rapidly lost from this tissue, probably due to
excretion by the biliary pathway (Porteous et al., 2013). These
findings suggest that the rapid initial formation of MitoClick in
the heart following a single i.v. injection of its precursors may
be used to infer changes in Dcp and Dcm in vivo. However, it is
important to note that the factors that determine MitoClick for-
mation in vivo are quite different from those that dominate for
cells in culture. In vivo, MitoOct and MitoAzido do not have the
opportunity to equilibrate with Dcp and Dcm as they do in cells.
In contrast, kinetic factors such as blood flow, tissue uptake,
and excretion determine the initial uptake into cells and mito-
chondria. Even so, the local concentration of MitoOct and
MitoAzido within mitochondria by Dcp and Dcm suggests that
the initial formation of MitoClick in tissues reports on changes
in these potentials.
The response of MitoClick formation to changes in Dcm in the
heart was evaluated using the uncoupler 2,4-dinitrophenoletabolism 23, 379–385, February 9, 2016 ª2016 The Authors 383
(DNP). Uncoupling by DNP leads to pathological heat generation
in vivo and is known to decrease Dcm (Jucker et al., 2000). DNP
decreased the formation of MitoClick indicating that this
approach can be used to assess changes inDcmwithin the heart
in vivo (Figures 4B and 4C). MitoClick could be used to assess
the toxic effects of DNP and assist in the development of safer
formulations (Perry et al., 2015); however, we note that the
response of MitoClick formation in vivo to DNP administration
route and dose was not straightforward, presumably due to
DNP distribution and compensatory changes in mitochondrial
respiration and Dcm. Next, we used MitoClick to assess whether
there was a change in Dcm in a mouse model of heart mitochon-
drial dysfunction. We used a heart-specific Ndufs4-null strain
(Chouchani et al., 2014; Karamanlidis et al., 2013; Sterky et al.,
2012). Ndufs4 encodes an 18 kDa subunit of respiratory com-
plex I that plays a role in assembly and/or stability of the complex
(Karamanlidis et al., 2013). The Ndufs4-null mice had an 50%
decrease in complex I activity in the heart, and developed severe
cardiomyopathy (Chouchani et al., 2014; Karamanlidis et al.,
2013). We confirmed the decreased complex I activity (Fig-
ure 4D), and therefore expected to find a decrease in Dcm in
the heart due to defective proton pumping. To our great surprise,
MitoClick formation was actually elevated compared to control
mice (Figure 4E). One possibility was that MitoClick formation
increased within Ndufs4-null hearts due to a compensatory in-
crease in mitochondrial content. However, the mitochondrial
marker enzyme citrate synthase showed no such increase (Fig-
ure 4F). To see if there was a change in mitochondrial energetics,
we assessed isolated heart mitochondria in vitro, and this
showed that heart mitochondria from the Ndufs4-null mice had
a higher Dcm when respiring on succinate (Figure 4G), suggest-
ing a compensatory upregulation of Dcm generation from com-
plex II-linked substrates to counteract the complex I-linked
defect in the hearts of Ndufs4-null mice. This surprising result
inadvertently provided a good test for MitoClick and showed
that it can assess unexpected small changes in Dcm in vivo.
However, it is important to note that further work is required to
determine whether the relative change in MitoClick formation in
these mice could be in part due to changes in Dcp or mitochon-
drial volume. Even so, these findings with the Ndufs4-null mice
show how MitoClick can contribute to investigating subtle
changes to Dcm in the heart in vivo.
Conclusion
AsDcm is central tomitochondrial function and dysfunction, sub-
tle changes are of considerable significance for cell fate and
health. The difficulty of assessing small changes in Dcm in cells
and in vivo is a major impediment to understanding normal and
pathological mitochondrial function in a range of biomedically
important situations. Here we have developed a highly sensitive
approach that can contribute to the assessment of Dcm in cells
and in vivo, and shown its utility in proof of principle experiments.
A unique aspect of the approach is that it utilizes Dcm- and
Dcp-dependent uptake and reaction together of two cations to
form a diagnostic product, MitoClick. Consequently, the rate of
MitoClick formation is particularly sensitive to small changes in
Dcm and Dcp due to the logarithmic relationship of uptake of
both cations to these potentials. Transformation of potential
measurement from a reversible compound distribution to an384 Cell Metabolism 23, 379–385, February 9, 2016 ª2016 The Authoirreversible reaction rate circumvents the hitherto intractable
problem of compound redistribution during sample work up.
Consequently, changes inDcm andDcp can be assessed in vivo,
within whole organs or organisms, and the MitoClick approach
opens up new ways of exploring subtle mitochondrial changes.
There are constraints to this approach that should be borne in
mind. The first is that uptake of MitoAzido and MitoOct within
mitochondria will also be affected by Dcp; therefore changes in
this variable must also be considered before concluding that
MitoClick formation is related to an alteration to Dcm. A further
point is that MitoClick formation is the weightedmean of all mito-
chondria analyzed, and therefore gives average values of Dcm
andDcp in the sample. Complementary methods will be required
to assess whetherDcm orDcp changes in individual cells ormito-
chondria. It is also important to consider whether changes in
MitoClick formation are influenced by mitochondrial content,
as was addressed herein by measurement of a marker enzyme.
A related consideration is that the local rate of formation of
MitoClick will be affected by changes in the organelle volume.
Therefore, although MitoClick formation is exquisitely sensitive
to subtle changes in Dcm, this very sensitivity means that we
must be cautious in ascribing changes in MitoClick formation
solely to Dcm. However, these limitations apply to most methods
routinely used to assess Dcm in cells.
The concentration of two TPP compounds simultaneously
within mitochondria to assemble a new compound suggests
that mitochondria can be used as a ‘‘reaction chamber.’’ This
could facilitate the generation of new bioactive, therapeutic, or
toxic compounds locally withinmitochondria, but with the precur-
sors having minimal effects. This approach has been suggested
previously, but using nonspecific functions (Rideout, 1994;Roten-
berg et al., 1991); thus the development of TPP-conjugated click
reagents opens up a new methodology for future development.
To conclude, we have shown that it is possible to assess small
changes in Dcm and Dcp in cells in culture and in vivo using of
mitochondria-targeted click reagents. This development opens
up many new possibilities for assessing changes in these poten-
tials in physiological and pathological processes.EXPERIMENTAL PROCEDURES
Synthesis and In Vitro Analysis of MitoAzido, MitoOct, and MitoClick
The syntheses and characterization of MitoAzido, MitoOct, and MitoClick and
their deuterated internal standards (IS) are described in the Supplemental
Information.
Cell Culture
C2C12 cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM;
Invitrogen) supplementedwith 10%FCS. To assessDcm by fluorescentmicro-
scopy, we used TMRM as described in the Supplemental Information.
Mouse Experiments
All animal experiments were carried out in accordance with the UK Animals
(Scientific Procedures) Act 1986 and the University of Cambridge Animal Wel-
fare Policy. For the time course studies, male 8- to 10-week-old C57BL/6 mice
were used. The heart-specific Ndufs4-null strain was a gift from Nils-Go¨ran
Larsen, Ko¨ln (Chouchani et al., 2014; Sterky et al., 2012). Mice were adminis-
tered MitoOct and MitoAzido by tail vein injection and were then killed by cer-
vical dislocation with tissues being isolated and snap-frozen on liquid nitrogen.
MitoOct, MitoAzido, and MitoClick were extracted from the mouse tissues as
described in the Supplemental Information.rs
LC-MS/MS Analysis
Sampleswere analyzedbyLC-MS/MSwithmultiple reactionmonitoring inpos-
itive ionmodeafter reverse-phase separationonan I-classAcquity LCattached
to a Xevo TQ-S triple quadrupole mass spectrometer (Waters), analyzed using
MassLynx software. Standard curves were prepared and processed in parallel
using the appropriate biologicalmaterial or buffer spikedwithd15-MitoOct,d15-
MitoAzido, and d30-MitoClick ISs and various amounts of MitoOcttet, MitoA-
zido, andMitoClick. Standard curves for the response ofMitoOcttet,MitoAzido,
and MitoClick relative to its deuterated IS against concentration were linear
over the range 1–1,000 pmol with R2 routinely >0.99 (see Figure S3D).
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, two tables, supplemental
calculations, and Supplemental Experimental Procedures and can be found
with this article online at http://dx.doi.org/10.1016/j.cmet.2015.11.014.
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